Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16966689

J. Clin. Oncol. 2006 Oct 10 24 29 4758-63

Download in:

View as

General Info

PMID
16966689